The Ensign Group (ENSG) Stock Price, News & Analysis

Company Overview

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Key Stats

• Today's Range: $127.23 to $131.11
• 50-Day Range: $125.40 to $148.86
• 52-Week Range: $113.27 to $158.45
• Volume: 319,961 shs
• Average Volume: 415,247 shs
• Market Capitalization: $7.50 billion
• P/E Ratio: 25.53
• Dividend Yield: 0.19%
• Price Target: $165.17
• Consensus Rating: Moderate Buy

The Ensign Group Stock Analysis - MarketRank™

The Ensign Group scored higher than 96% of companies evaluated by MarketBeat, and ranked 39th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

The Ensign Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

The Ensign Group has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 10.38%

Earnings Growth

Earnings for The Ensign Group are expected to grow by 10.38% in the coming year, from $5.59 to $6.17 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of The Ensign Group is 25.53, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.

Price to Earnings Ratio vs. Sector

The P/E ratio of The Ensign Group is 25.53, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.44.

Price to Earnings Growth Ratio

The Ensign Group has a PEG Ratio of 1.52. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

The Ensign Group has a P/B Ratio of 4.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.51% of the float of The Ensign Group has been sold short.

Short Interest Ratio / Days to Cover

The Ensign Group has a short interest ratio ("days to cover") of 5.8.

Change versus previous month

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

The Ensign Group has a dividend yield of 0.19%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

The Ensign Group has been increasing its dividend for 18 years.

Dividend Coverage

The dividend payout ratio of The Ensign Group is 4.89%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, The Ensign Group will have a dividend payout ratio of 4.05% next year. This indicates that The Ensign Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.84

Percentage of Shares Shorted

4.51% of the float of The Ensign Group has been sold short.

Short Interest Ratio / Days to Cover

The Ensign Group has a short interest ratio ("days to cover") of 5.8.

Change versus previous month

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 1.63

News Sentiment

The Ensign Group has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for The Ensign Group this week, compared to 7 articles on an average week.

MarketBeat Follows

4 people have added The Ensign Group to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, The Ensign Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,345,115.00 in company stock.

Percentage Held by Insiders

Only 3.90% of the stock of The Ensign Group is held by insiders.

Percentage Held by Institutions

96.12% of the stock of The Ensign Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ENSG Stock Analysis - Frequently Asked Questions

How have ENSG shares performed this year?

The Ensign Group's stock was trading at $132.86 at the start of the year. Since then, ENSG stock has decreased by 1.8% and is now trading at $130.45.
View the best growth stocks for 2025 here.

How were The Ensign Group's earnings last quarter?

The Ensign Group, Inc. (NASDAQ:ENSG) issued its quarterly earnings results on Wednesday, February, 5th. The company reported $1.36 earnings per share for the quarter, missing analysts' consensus estimates of $1.47 by $0.11. The Ensign Group had a net margin of 6.99% and a trailing twelve-month return on equity of 17.07%.

When did The Ensign Group's stock split?

Shares of The Ensign Group split on Thursday, December 24th 2015. The 2-1 split was announced on Wednesday, December 9th 2015. The newly minted shares were issued to shareholders after the closing bell on Wednesday, December 23rd 2015. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How do I buy shares of The Ensign Group?

Shares of ENSG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of The Ensign Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Ensign Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Netflix (NFLX).

Company Calendar

• Record date for 1/31 Dividend: 12/31/2024
• Ex-Dividend for 1/31 Dividend: 12/31/2024
• Dividend Payable: 1/31/2025
• Last Earnings: 2/05/2025
• Record date for 4/30 Dividend: 3/31/2025
• Ex-Dividend for 4/30 Dividend: 3/31/2025
• Today: 4/02/2025
• Next Earnings (Estimated): 4/29/2025
• Dividend Payable: 4/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Skilled nursing care facilities
• Sub-Industry: Health Care Facilities
• Current Symbol: NASDAQ:ENSG
• CIK: 1125376
• Web: www.ensigngroup.net
• Phone: (949) 487-9500
• Fax: 949-540-3007
• Employees: 29,900
• Year Founded: 1999

Price Target and Rating

• Average Stock Price Target: $165.17
• High Stock Price Target: $175.00
• Low Stock Price Target: $155.00
• Potential Upside/Downside: +26.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $5.11
• Trailing P/E Ratio: 25.53
• Forward P/E Ratio: 23.34
• P/E Growth: 1.52
• Net Income: $297.97 million
• Net Margins: 6.99%
• Pretax Margin: 9.06%
• Return on Equity: 17.07%
• Return on Assets: 6.47%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 1.56
• Quick Ratio: 1.56

Sales & Book Value

• Annual Sales: $4.26 billion
• Price / Sales: 1.76
• Cash Flow: $6.73 per share
• Price / Cash Flow: 19.37
• Book Value: $32.03 per share
• Price / Book: 4.07

Miscellaneous

• Outstanding Shares: 57,455,000
• Free Float: 55,214,000
• Market Cap: $7.50 billion
• Optionable: Optionable
• Beta: 0.98